MetLife is expected to report Q1 2026 consensus revenue of $19.2 billion, representing 2.0% year-over-year growth, and an adjusted EPS of $2.23, while the current stock price of $78.95 trades at a significant discount to the $93.38 analyst price target.
Investors are primarily focused on the recovery of Variable Investment Income (VII), which is projected to rebound strongly after a period of pressure from alternative asset valuations.
Management recently bolstered sentiment by declaring a 4.4% dividend increase and outlining its 'New Frontier' strategy, which targets double-digit adjusted EPS growth through 2029. However, analysts are closely monitoring potential headwinds from base spread compression and private credit exposure within the life insurance sector.